Covid-19. Other coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: The propolis supplement is taken as a 500 mg capsule twice a day for 1 month. Intervention 2: Control group: The placebo is taken as a capsule twice a day for 1 mon
Sponsors
Abadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients aged 18 to 65 years Laboratory confirmation of Covid-19 (2019-nCoV Real-Time RT-PCR)
Exclusion criteria
Exclusion criteria: Pregnancy and lactation, a history of allergies to honey and bee products, uncontrolled underlying disease including neuropsychiatric problems, diabetes, thyroid disorders, heart disease, chronic liver or kidney failure, and autoimmune diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination.;Oxygen saturation. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination.;Respiratory rate. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination.;Body temperature. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination.;LI-6. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA.;TNF alpha. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA.;Crp-hs. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA.;CBC. Timepoint: First and 30 days after the intervention. Method of measurement: Cell counter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Malihi
Abadan University of Medical Sciences
Outcome results
None listed